Neuberger Berman High Yield Strategies Fund (NYSEAMERICAN:NHS - Get Free Report) was the target of a large drop in short interest in the month of September. As of September 30th, there was short interest totaling 35,540 shares, a drop of 35.2% from the September 15th total of 54,819 shares. Currently, 0.1% of the company's shares are sold short. Based on an average trading volume of 350,107 shares, the short-interest ratio is currently 0.1 days.
Neuberger Berman High Yield Strategies Fund Trading Up 0.2%
Shares of NYSEAMERICAN:NHS opened at $5.35 on Friday. The firm's 50 day simple moving average is $5.74 and its 200 day simple moving average is $6.10. Neuberger Berman High Yield Strategies Fund has a fifty-two week low of $5.26 and a fifty-two week high of $7.75.
Neuberger Berman High Yield Strategies Fund Announces Dividend
The company also recently announced a monthly dividend, which will be paid on Friday, October 30th. Shareholders of record on Thursday, October 15th will be paid a $0.0905 dividend. This represents a $1.09 annualized dividend and a yield of 20.3%. The ex-dividend date of this dividend is Thursday, October 15th.
Institutional Investors Weigh In On Neuberger Berman High Yield Strategies Fund
Several hedge funds have recently bought and sold shares of NHS. EP Wealth Advisors LLC bought a new position in shares of Neuberger Berman High Yield Strategies Fund during the second quarter worth $71,000. Cura Wealth Advisors LLC bought a new position in Neuberger Berman High Yield Strategies Fund during the second quarter worth about $77,000. CoreCap Advisors LLC bought a new position in Neuberger Berman High Yield Strategies Fund during the second quarter worth about $119,000. Equitable Holdings Inc. acquired a new position in Neuberger Berman High Yield Strategies Fund in the second quarter valued at about $287,000. Finally, Readystate Asset Management LP acquired a new position in Neuberger Berman High Yield Strategies Fund in the second quarter valued at about $325,000.
Neuberger Berman High Yield Strategies Fund Company Profile
(
Get Free Report)
Neuberger Berman High Yield Strategies Fund, Inc is a closed-end investment fund listed on the NYSE American under the symbol NHS. The fund seeks to provide a high level of current income, with capital appreciation as a secondary objective, by investing primarily in high-yield debt securities and other income-producing investments.
The fund generally invests in below-investment-grade corporate bonds, notes, loans and other fixed-income obligations. These securities may be issued by companies in a range of industries and geographic markets, including the United States and international markets.
Further Reading
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Neuberger Berman High Yield Strategies Fund, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Neuberger Berman High Yield Strategies Fund wasn't on the list.
While Neuberger Berman High Yield Strategies Fund currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Tesla, Nvidia, and Google helped shape the last era of market growth, but the next wave could come from a new group of companies. Inside this report, you’ll find 7 stocks that could play a major role in the next tech-driven market boom.
Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Like this article? Share it with a colleague.
Link copied to clipboard.